Treatment Of Chemotherapy Articles & Analysis
9 articles found
Leukemia, a malignant disorder of the blood and bone marrow, poses significant challenges to both patients and healthcare providers. Traditional treatments, including chemotherapy and radiation, while effective for some, often come with severe side effects and varied success rates. ...
At present, some commonly used technologies for breast cancer treatment include surgery, chemotherapy, radiation therapy, hormone therapy, targeted therapy, and immunotherapy. ...
Background and objective High grade serous carcinoma (HGSC) of the ovary is a complex and deadly disease. Although frontline treatment of chemotherapy and surgery is often effective, with nearly all patients experiencing remission, over 80% of patients will experience disease recurrence in the first two years and ultimately die of the disease. ...
In order to more effectively deliver chemotherapy drugs, Small Molecule Drug Conjugates (SMDC), Antibody Drug Conjugates (ADC), and Degradation Antibody Conjugates (DAC) have been successively explored and developed, enhancing the therapeutic index while providing selective delivery. ...
Currently, multiple antibody drugs have been approved for the treatment of various diseases, such as cancer, autoimmune diseases, and infectious diseases. Antibody drugs have become an important means of treating some diseases, while also providing clinicians with more treatment options. For example, monoclonal or polyclonal antibodies have been used in some ...
Abstract We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. ...
Only beneficiaries with specific cancer diagnoses and who are receiving systemic chemotherapy treatment (excluding exclusively hormonal therapies) are eligible for EOM, these include: breast cancer, lung cancer, lymphoma, multiple myeloma, small intestine/colorectal, prostate cancer, and chronic leukemia. ...
New collaborative research from Queen’s University Belfast, the University of Split, Croatia and King’s College London has shown that the response to the outbreak of the coronavirus disease 2019 (COVID-19) is significantly affecting the treatment and care of patients with cancer. The research, recently published in the European Journal of Cancer, highlights how the ...
In 2017, CAR-T therapy was first approved by the FDA for the treatment of blood cancers such as leukemia and lymphoma. The successful application of CAR-T therapy has renewed hope for many desperate people, who are waiting for bone marrow matching. ...